Brazil Microfluidics Market Size & Outlook, 2023-2030
Brazil microfluidics market, 2018-2030 (US$M)
Related Markets
Brazil microfluidics market highlights
- The Brazil microfluidics market generated a revenue of USD 653.1 million in 2023 and is expected to reach USD 1,459.7 million by 2030.
- The Brazil market is expected to grow at a CAGR of 12.2% from 2024 to 2030.
- In terms of segment, medical was the largest revenue generating technology in 2023.
- Medical is the most lucrative technology segment registering the fastest growth during the forecast period.
Microfluidics market data book summary
| Market revenue in 2023 | USD 653.1 million |
| Market revenue in 2030 | USD 1,459.7 million |
| Growth rate | 12.2% (CAGR from 2023 to 2030) |
| Largest segment | Medical |
| Fastest growing segment | Medical |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Medical, Non-Medical |
| Key market players worldwide | Illumina Inc, Roche Holding AG ADR, PerkinElmer, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Abbott Laboratories, Thermo Fisher Scientific Inc, Standard BioTools Inc |
Other key industry trends
- In terms of revenue, Brazil accounted for 2.0% of the global microfluidics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil microfluidics market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 633.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Microfluidics Market Scope
Microfluidics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil microfluidics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microfluidics market will help companies and investors design strategic landscapes.
Medical was the largest segment with a revenue share of 84.12% in 2023. Horizon Databook has segmented the Brazil microfluidics market based on medical, non-medical covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil is the largest country and economy in Latin America; it accounts for about 60% of the region’s GDP. The country is one of the most attractive & emerging markets for the life sciences industry. Government efforts for the development of local biotechnology, pharmaceutical, and medical equipment industries are anticipated to boost market growth.
Research activities to explore the potential of microfluidics have been increasing in Brazil. In April 2016, researchers from Brazil developed a microchip that could diagnose 18 types of cancer simultaneously. The biosensor developed is such that the 15-min blood test diagnoses 18 types of cancer. Such early diagnosis of cancer raised the chances of being treated by 70% without any harmful radiations.
Moreover, the country offers lucrative opportunities for international companies operating in the microfluidics industry. For instance, Elveflow, a French microfluidics manufacturer, acknowledged the requirements of Brazilian microfluidics market, offering flow control equipment that require minimal time while maintaining accuracy of final results.
Reasons to subscribe to Brazil microfluidics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil microfluidics market databook
-
Our clientele includes a mix of microfluidics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil microfluidics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil microfluidics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil microfluidics market size, by technology, 2018-2030 (US$M)
Brazil Microfluidics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
